Literature DB >> 806883

Brucellosis in childhood.

L Street, W W Grant, J D Alva.   

Abstract

Brucellosis has always been an unusual disease in children and, concomitant with the control of the disease in domestic animals, reports have become sparse. The pediatrician, therefore, may not be aware of the protean clinical manifestations of childhood brucellosis. In 1973, nine cases occurred during a three-month period in El Paso, Texas. All cases were marked by spiking fevers and lethargy of four days to four weeks in duration. Tender hepatomegaly or splenomegaly was striking in seven patients. Other characteristics included epistaxis, arthralgia, myalgia, and weight loss. Leukopenia and leukemoid reaction were found in five patients. All of the patients tested had elevated liver enzymes. Febrile agglutinins were invaluable in screening for an early clue to diagnosis. When Brucella abortus antigen agglutinated serum from patients with a positive screen in dilutions greater than 1:320, a presumptive diagnosis of brucellosis was made. Brucella was isolated from the blood or bone marrow in seven patients and the time of incubation proved crucial for successful recovery. Bacterial blood cultures are usually discarded at ten days of age, as were cultures from the only two patients from whom the organism was not recovered. All of the cultures incubated for 12 to 15 days grew B. melitensis, an unusual causative species in the United States. However, several patients admitted eating cheese from the State of Chihuahua, Mexico, made from unpasteurized goat's milk, the presumed source of the infection. Within one to three days, all patients responded dramatically to antibiotics; tetracycline was given orally for 21 days and streptomycin intramuscularly for 14 days. Pediatricians caring for patients in areas where consumption of unpasteurized milk products is likely would do well to consider brucellosis in a child with obscure fever or toxic hepatosplenomegaly.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 806883

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Childhood brucellosis in north-western Greece: a retrospective analysis.

Authors:  E Galanakis; K L Bourantas; S Leveidiotou; P D Lapatsanis
Journal:  Eur J Pediatr       Date:  1996-01       Impact factor: 3.183

2.  Brucella arthritis in children.

Authors:  M Lubani; D Sharda; I Helin
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

3.  Serology, clinical manifestations and treatment of brucellosis in different age groups.

Authors:  J D Colmenero; J M Reguera; F P Cabrera; J M Cisneros; D L Orjuela; J Fernández-Crehuet
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

4.  Haematological manifestations of childhood brucellosis.

Authors:  Y al-Eissa; M al-Nasser
Journal:  Infection       Date:  1993 Jan-Feb       Impact factor: 3.553

5.  Neonatal brucellosis.

Authors:  M M Lubani; K I Dudin; D C Sharda; N M Abu Sinna; T Al-Shab; A A Al-Refe'ai; S M Labani; A Nasrallah
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

6.  Soft tissue mass of the chest wall as the sole manifestation of brucellosis in a 7-year-old boy.

Authors:  Mohammed S Al-Ayed; Ibrahim Z Bin-Hussain; Sami Al Hajjar; Saleh Al Nassar
Journal:  Ann Saudi Med       Date:  2011 May-Jun       Impact factor: 1.526

7.  The U.S.-Mexico Border Infectious Disease Surveillance project: establishing bi-national border surveillance.

Authors:  Michelle Weinberg; Stephen Waterman; Carlos Alvarez Lucas; Veronica Carrion Falcon; Pablo Kuri Morales; Luis Anaya Lopez; Chris Peter; Alejandro Escobar Gutiérrez; Ernesto Ramirez Gonzalez; Ana Flisser; Ralph Bryan; Enrique Navarro Valle; Alfonso Rodriguez; Gerardo Alvarez Hernandez; Cecilia Rosales; Javier Arias Ortiz; Michael Landen; Hugo Vilchis; Julie Rawlings; Francisco Lopez Leal; Luis Ortega; Elaine Flagg; Roberto Tapia Conyer; Martin Cetron
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.